Cxcr6 was recently described to promote the maintenance of cytotoxic CD8 T cells in tumors through interactions with Ccr7+ dendritic cells52, a potential factor how Snx9 KO OTI cells may enhance the endogenous anti-tumor immune response. The gene discussed is CD8A; the disease is neoplasm.